4 Drug Stocks Facing FDA Approval Decisions in July

Description:

According to Adam Feuerstein, " Four FDA drug approval decisions in July -- headlined by another weight-loss drug and a prescription fish oil pill with blockbuster potential -- will keep biotech investors busy in what is normally one of the sector's slower months." Read more here.

>>Also: Hot Biotech Stocks Traded by Hedge Funds

>>Also: 22 Biopharma Stocks With Breakout Potential in 2012

Most Viewed Portfolios

View All

Articles

5 Big Stocks to Trade for Gains as QE3 Ends

10.30.14 | 11:03 AM

BALTIMORE (Stockpickr) -- The Fed is shutting the tap this week, ending the QE3 bond-.buying program that's arguably been one of the biggest struct...

5 Stocks Spiking on Unusual Volume

10.30.14 | 07:00 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter